SCHEMBL20272283

SCHEMBL20272283

O=C(/C=C/C1OCCC12CCCCCCCCC2)Nc1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ USP2 O75604 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ EPHX1 P07099 1/20 0.41
▸ MEN1 O00255 8/20 0.40
▸ KMT2A Q03164 8/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HTR1E P28566 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ S1PR3 Q99500 1/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ RECQL P46063 2/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ MAPT P10636 5/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ HCAR2 Q8TDS4 1/20 0.38
▸ POLB P06746 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18598053 1.00 ALDH1A1 (0.45) ALDH1A1USP2HPGDEPHX1MEN1
SCHEMBL19425317 0.78 ALDH1A1 (0.45) ALDH1A1USP2HPGDEPHX1MEN1
SCHEMBL20705573 0.76 MEN1 (0.46) ALDH1A1HPGDEPHX1MEN1KMT2A
SCHEMBL20272262 0.71 EPHX1 (0.45) ALDH1A1USP2HPGDEPHX1MEN1
SCHEMBL21515098 0.67 LPAR2 (0.67) ALDH1A1MEN1KMT2ACYP1A2MAPT
SCHEMBL13381356 0.67 LPAR2 (0.67) ALDH1A1MEN1KMT2ACYP1A2MAPT
SCHEMBL11586886 0.67 LPAR2 (0.67) ALDH1A1MEN1KMT2ACYP1A2MAPT
SCHEMBL18467672 0.67 ALDH1A1 (0.46) ALDH1A1USP2HPGDEPHX1MEN1
SCHEMBL1380888 0.64 FYN (0.62) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL15309134 0.64 RAB9A (0.59) ALDH1A1USP2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000511-B2 Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-06-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000511-B2 Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders MCL1, BCL2, BCL2L1 ALDH1A1 2862/4885USP2 1310/4885HPGD 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback